Brief: Jury Enters Verdict That Certain Of Angiodynamics Inc's Implantable Port Products Infringe Certain U.S. Patents Held By BARD

AngioDynamics

23/11/2022 21:51

Nov 23 (Reuters) - AngioDynamics Inc  ANGO.O :
    * ANGIODYNAMICS INC - ON NOV 22, 2022, , JURY ENTERED
VERDICT THAT
CERTAIN OF CO'S IMPLANTABLE PORT PRODUCTS INFRINGE CERTAIN U.S.
PATENTS HELD BY BARD
    * ANGIODYNAMICS INC - ISSUE OF DAMAGES WAS BIFURCATED BY
COURT
DURING TRIAL, WAS NOT DETERMINED BY JURY AND WILL BE SUBJECT TO
A SEPARATE PROCEEDING
    * ANGIODYNAMICS INC - COMPANY BELIEVES IT HAS MERITORIOUS
DEFENSES, POSITIONS WITH RESPECT TO THE MATTERS REMAINING TO BE
DECIDED AND THE JURY DECISION
    * ANGIODYNAMICS INC - INTENDS TO VIGOROUSLY PURSUE ALL
AVAILABLE
REMEDIES AND DEFENSES, INCLUDING POST-TRIAL MOTIONS AND APPEALS

Source: (shorturl.at/EIJPR)
Further company coverage:  ANGO.O 
 ((Reuters.Briefs@thomsonreuters.com;))